Results 141 to 150 of about 37,422 (167)

Engram cell vulnerability in neurodegeneration: from mechanistic insights to therapeutic horizons. [PDF]

Front Aging Neurosci
Bai Q, Yan Y, Zeng C, Li X, Zeng G, Saidova A, Li H, Qing H.   +7 more
europepmc   +1 more source

Clearance of Early Complement Protein From CSF After Aneurysmal Subarachnoid Hemorrhage and Influence on Neurologic Outcome. [PDF]

Neurol Neuroimmunol Neuroinflamm
Geraghty JR, Katz EA, Butler M, Testai FD.   +3 more
europepmc   +1 more source

Targeting Complement Component 1q Ameliorates Diabetic Endothelial Inflammation Via Orphan Nuclear Receptor 4a1-Dependent Suppression of Nuclear Factor κB Signaling. [PDF]

J Am Heart Assoc
Mao A, Shi X, Li Z, Zhang K, Kan H, Geng L, Zhou T, He D.   +7 more
europepmc   +1 more source

The delta-opioid receptor: a therapeutic target for Alzheimer's disease. [PDF]

Front Aging Neurosci
Xu Y, Guan W, Yang Y, Yang Y, Xia Y, Peng Y.   +5 more
europepmc   +1 more source

Profiling complement proteins in pediatric tuberculosis children with or without serological evidence of prior SARS-CoV-2 exposure. [PDF]

Front Immunol
Kumar NP, Mohan G, Balaji S, Vanamudhu A, R P, Ramraj B, Devi PG, Ahamed SF, M K, S G, Adavath SK, C HG, Varadarajan P, Babu S, Venkataraman A.   +14 more
europepmc   +1 more source

Targeting microglial C1q alleviates blood-brain barrier disruption in the thalamus after cortical infarction. [PDF]

J Neuroinflammation
Peng L, Chen M, Zuo X, Wu X, Gong M, Qin Z, Sun W, Xu E.   +7 more
europepmc   +1 more source

TREM2 receptor protects against complement-mediated synaptic loss by binding to complement C1q during neurodegeneration

Immunity, 2023
Zhihao Lin, Dan-Dan Hu, Yujuan Hong
exaly  

Human anti-C1q autoantibodies bind specifically to solid-phase C1q and enhance phagocytosis but not complement activation

Proceedings of the National Academy of Sciences of the United States of America, 2023
Leendert Trouw, Gestur Vidarsson, Arnaud Zaldumbide   +2 more
exaly  

Circulating C1q levels in health and disease, more than just a biomarker

Molecular Immunology, 2021
Leendert Trouw, Douwe Dijkstra, Cees van Kooten   +2 more
exaly